Skip to
  1. Homepage
  2. Research and trials
  3. Clinical trials
Search by disease/gene

Search by disease/gene

*
(*) mandatory field


 

Other search option(s)

Cloric : A Phase II Open-Label, Multicenter, Non Randomized Study Evaluating the Efficacy and the Safety of Clofarabine in Combination With IV Busulfan and Thymoglobulin (CBT) as a Reduced Intensity Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Adult Patients With High-Risk AML, MDS or ALL

Type of clinical trial   Cell therapy clinical trial, Protocol clinical trial
Recruiting project   No
Orpha number ORPHA207971
Status   Ongoing trial
Website
Geographic coverage National
Funding body(ies) -
Sponsor Chu nantes 

Principal investigator of clinical trial :  
Dr Patrice CHEVALLIER
Service d'hématologie clinique
CHU de Nantes - Hôtel Dieu
1 place Alexis Ricordeau
44093 NANTES CEDEX 1
FRANCE
More information

Phone  : 33 (0)2 40 08 32 53
Fax  : 33 (0)2 40 08 32 50

Website


Sponsor of clinical trial :  
CHU NANTES
CHU Nantes
CHU de Nantes
5 Allée de l'Ile Gloriette
44093 NANTES CEDEX 1
FRANCE
More information

Phone  : 33 (0)2 53 48 28 35
Fax  : 33 (0)2 53 48 28 36
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.